Diabetes Obes Metab (2019) 21(2):23443
While this is educational information rather than medical advice, understanding the most common applications can help you determine if further research is warranted for your situation
Top companies in the market include Novo Nordisk A/S, Eli Lilly and Company, Sanofi and AstraZeneca North America dominated the market in 2024, holding the largest revenue share of 68.4%
If it happens to you, its a problem. The ocular risks of GLP-1RAs While GLP-1RAs are very positive and transformative pharmaceutical agents for chronic disease management, the report states, they have been associated with exacerbation of age-related macular degeneration, progression of diabetic retinopathy, and, most seriously, NAION
Historically, Medicare coverage for weight-loss treatment has been limited
This pattern is mechanistically expected